e-Therapeutics (LSE:ETX) Other Operating Expense : £0.00 Mil (TTM As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics Other Operating Expense?

e-Therapeutics's Other Operating Expense for the six months ended in Jul. 2023 was £0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jul. 2023 was £0.00 Mil.

e-Therapeutics's quarterly Other Operating Expense increased from Jul. 2022 (£-0.00 Mil) to Jan. 2023 (£0.00 Mil) but then stayed the same from Jan. 2023 (£0.00 Mil) to Jul. 2023 (£0.00 Mil).

e-Therapeutics's annual Other Operating Expense stayed the same from Jan. 2021 (£0.00 Mil) to Jan. 2022 (£0.00 Mil) but then declined from Jan. 2022 (£0.00 Mil) to Jan. 2023 (£0.00 Mil).

e-Therapeutics Other Operating Expense Historical Data

The historical data trend for e-Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics Other Operating Expense Chart

e-Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Other Operating Expense

Get a 7-Day Free Trial

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

e-Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jul. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

e-Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics (LSE:ETX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

ETXPF:USA

Address

4 Kingdom Street, Paddington, London, GBR, W2 6BD

Website

https://www.etherapeutics.co.uk

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics (LSE:ETX) Headlines

From GuruFocus

Eaton Vance Municipal Income 2028 Term Trust Announces Telephonic Annual Meeting Of Shareholders On November 12, 2021

By PRNewswire PRNewswire • 11-02-2021